. Author manuscript; available in PMC: 2016 Jun 1.

Published in final edited form as: J Biomed Inform. 2015 May 7;55:249–259. doi: 10.1016/j.jbi.2015.04.011

Table V.

Impact of technology characteristic (alert message actionabilitylow/high) on effective communication (perceived usefulness) and clinical impact (uptake) of pharmacogenomics clinical decision support (PGx-CDS) among fifty-seven encounters with the third through fifth clinical case scenarios.

Perceived usefulness of PGx-CDS with low and high alert message actionability (n=57)	Odds Ratio (95% CI)
Genetic test results usefulness	0.74 (0.38, 0.97)
Gene specific resources usefulness	1.07 (0.63, 1.81)
Alert message usefulness	0.53 (0.18, 1.53)
Alert message evidence usefulness	1.50 (0.65, 3.39)

Uptake of semi-active PGx-CDS with low and high alert message actionability (n=57)	Odds Ratio (95% CI)
Gene specific resources used	0.91 (0.21, 3.98)
Alert message evidence used	0.91 (0.26, 3.17)

CI = confidence interval